Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
Conditions
- Axial Spondyloarthrithis
- Ankylosing Spondylitis
Interventions
- BIOLOGICAL: Certolizumab Pegol
- OTHER: Placebo
Sponsor
UCB BIOSCIENCES GmbH
Collaborators